ProQR Therapeutics (PRQR) Operating Expenses (2012 - 2026)
ProQR Therapeutics (PRQR) posted Operating Expenses of $18.4 million for Q1 2026, down 85.09% sequentially from $123.1 million in Q4 2025, and up 12.19% YoY from $16.4 million in Q1 2025.
ProQR Therapeutics (PRQR) Operating Expenses (2012 - 2026) Analysis & Trends
ProQR Therapeutics has reported Operating Expenses for 15 years, with the latest figure at $18.4 million in Q1 2026.
- Quarterly Operating Expenses rose 12.19% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.5 million (up 28.4% YoY) and the FY2025 annual result came in at $69.6 million, up 30.22% from the prior year.
- Operating Expenses eased to $18.4 million in Q1 2026 per PRQR's latest filing, from $123.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $127.9 million in Q4 2022 and troughed at -$20.9 million in Q3 2022.
- A 5-year average of $17.0 million and a median of -$10.8 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 729.12% in 2022, then slumped 69.5% in 2025.
- Over 5 years, Operating Expenses stood at $127.9 million in 2022, then tumbled by 40.88% to $75.6 million in 2023, then rose by 20.83% to $91.4 million in 2024, then soared by 34.75% to $123.1 million in 2025, then tumbled by 85.09% to $18.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $18.4 million, $123.1 million, and -$16.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 18.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.36 Mn |
| Dec 31, 2025 | 123.12 Mn |
| Sep 30, 2025 | -16.60 Mn |
| Jun 30, 2025 | -18.36 Mn |
| Mar 31, 2025 | 16.36 Mn |
| Dec 31, 2024 | 91.38 Mn |
| Sep 30, 2024 | -13.94 Mn |
| Jun 30, 2024 | -10.83 Mn |
| Mar 31, 2024 | -13.83 Mn |
| Dec 31, 2023 | 75.62 Mn |
| Sep 30, 2023 | -9.54 Mn |
| Jun 30, 2023 | -10.95 Mn |
| Mar 31, 2023 | -10.83 Mn |
| Dec 31, 2022 | 127.90 Mn |
| Sep 30, 2022 | -20.88 Mn |
| Jun 30, 2022 | -17.99 Mn |
| Mar 31, 2022 | -20.51 Mn |
| Dec 31, 2021 | -20.33 Mn |
| Sep 30, 2021 | -18.53 Mn |
| Jun 30, 2021 | -16.69 Mn |